{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:03:44Z","timestamp":1789693424939,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022817","name":"Lanzhou University Second Hospital","doi-asserted-by":"publisher","award":["CY2023-BJ-08"],"award-info":[{"award-number":["CY2023-BJ-08"]}],"id":[{"id":"10.13039\/100022817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022817","name":"Lanzhou University Second Hospital","doi-asserted-by":"publisher","award":["CY2024-MS-B08"],"award-info":[{"award-number":["CY2024-MS-B08"]}],"id":[{"id":"10.13039\/100022817","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cellsig.2026.112831","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:27:09Z","timestamp":1787095629000},"page":"112831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel peptide encoded by circTLL1 drives osimertinib resistance in lung cancer by modulating the NT5C2\/Ras\/PI3K axis"],"prefix":"10.1016","volume":"148","author":[{"given":"Miao","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-yuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-xin","family":"Xv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112831_bb0005","article-title":"Unresectable stage III non-small-cell lung cancer: state of the art and challenges","volume":"0","author":"Jordi","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112831_bb0010","article-title":"The changing treatment landscape of EGFR-mutant non-small-cell lung cancer","volume":"22","author":"Fei","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112831_bb0015","article-title":"Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management","volume":"19","author":"Alissa","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2026.112831_bb0020","article-title":"Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC - mechanisms and evolving treatment approaches","volume":"0","author":"Jing","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2026.112831_bb0025","article-title":"EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy","volume":"0","author":"Shaheen","year":"2025","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112831_bb0030","article-title":"Osimertinib for EGFR-mutant non-small-cell lung cancer central nervous system metastases: current evidence and future perspectives on therapeutic strategies","volume":"18","author":"Sanjay","year":"2023","journal-title":"Target. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112831_bb0035","article-title":"Osimertinib for EGFR-mutant lung cancer with central nervous system metastases: a meta-analysis and systematic review","volume":"9","author":"Na","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.cellsig.2026.112831_bb0040","doi-asserted-by":"crossref","unstructured":"Antonio P, Pasi A J, Tony M, Solange P. Overcoming therapy resistance in EGFR-mutant lung cancer. Nat. Can. 2022;2(4). doi:https:\/\/doi.org\/10.1038\/s43018-021-00195-8.","DOI":"10.1038\/s43018-021-00195-8"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112831_bb0045","article-title":"Precision navigation through the labyrinth: overcoming EGFR resistance in non-small cell lung cancer","volume":"57","author":"Junhui","year":"2025","journal-title":"Ann. Med."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112831_bb0050","article-title":"Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer","volume":"121","author":"Alessandro","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"0","key":"10.1016\/j.cellsig.2026.112831_bb0055","article-title":"Acquired resistance mechanisms to osimertinib: the constant battle","volume":"116","author":"Z","year":"2023","journal-title":"Cancer Treat. Rev."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112831_bb0060","article-title":"Emerging role of noncoding RNAs in EGFR TKI-resistant lung cancer","volume":"14","author":"L","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112831_bb0065","article-title":"Non-coding RNAs in disease: from mechanisms to therapeutics","volume":"25","author":"N","year":"2023","journal-title":"Nat. Rev. Genet."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112831_bb0070","article-title":"Circular RNAs: characterization, cellular roles, and applications","volume":"185","author":"L","year":"2022","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112831_bb0075","article-title":"Circular RNA in cancer","volume":"24","author":"C","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112831_bb0080","article-title":"The expanding regulatory mechanisms and cellular functions of circular RNAs","volume":"21","author":"Ling-Ling","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112831_bb0085","article-title":"CircRNA and lncRNA-encoded peptide in diseases, an update review","volume":"23","author":"Qian","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112831_bb0090","article-title":"Translation and functional roles of circular RNAs in human cancer","volume":"19","author":"Ming","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112831_bb0095","article-title":"CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K\/AKT\/mTOR activation","volume":"23","author":"Yaming","year":"2024","journal-title":"Mol. Cancer"},{"issue":"0","key":"10.1016\/j.cellsig.2026.112831_bb0100","article-title":"A novel protein encoded by hsa_circ_0068626 contributes to age-related cataract via the p62\/Keap1\/Nrf2 signaling pathway-mediated ferroptosis","volume":"260","author":"Yuxin","year":"2025","journal-title":"Exp. Eye Res."},{"issue":"0","key":"10.1016\/j.cellsig.2026.112831_bb0105","article-title":"CircNFIB decreases synthesis of arachidonic acid and inhibits breast tumor growth and metastasis","volume":"963","author":"Shanliang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112831_bb0110","article-title":"Cytosolic 5\u2019-nucleotidase II is a sensor of energy charge and oxidative stress: a possible function as metabolic regulator","volume":"10","author":"Rossana","year":"2021","journal-title":"Cells"},{"issue":"0","key":"10.1016\/j.cellsig.2026.112831_bb0115","article-title":"Allosteric modulation of Ras and the PI3K\/AKT\/mTOR pathway: emerging therapeutic opportunities","volume":"5","author":"Paul","year":"2015","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112831_bb0120","article-title":"Mechanisms and management of 3rd-generation EGFR-TKI resistance in advanced non-small cell lung cancer (review)","volume":"59","author":"Jingyi","year":"2021","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112831_bb0125","article-title":"Clinical management in NSCLC patients with EGFR mutation after Osimertinib progression with unknown resistance mechanisms","volume":"18","author":"Xin","year":"2024","journal-title":"Clin. Respir. J."},{"issue":"0","key":"10.1016\/j.cellsig.2026.112831_bb0130","article-title":"Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: from mechanisms to therapeutics","volume":"345","author":"Riya","year":"2024","journal-title":"Life Sci."},{"issue":"0","key":"10.1016\/j.cellsig.2026.112831_bb0135","article-title":"The role of Chinese medicines in targeting non-coding RNAs to overcome cancer drug resistance: mechanisms and clinical translation challenges","volume":"222","author":"Guoming","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"0","key":"10.1016\/j.cellsig.2026.112831_bb0140","article-title":"Targeting non-coding RNAs to overcome osimertinib resistance in EGFR-mutated non-small cell lung cancer","volume":"14","author":"Beilei","year":"2024","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112831_bb0145","article-title":"CircRNA-miRNA interactions in atherogenesis","volume":"477","author":"Kind-Leng","year":"2022","journal-title":"Mol. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112831_bb0150","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Lasse","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112831_bb0155","article-title":"Comprehensive analysis of translation from overexpressed circular RNAs reveals pervasive translation from linear transcripts","volume":"48","author":"Hung","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112831_bb0160","article-title":"Functional characterization of a novel protein-coding circular RNA, circRNA_1193, from the mAAP gene in silkworm and its role in antiviral defense against BmCPV","volume":"16","author":"Song","year":"2025","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112831_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-4-1","article-title":"A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via hippo-YAP signaling","volume":"18","author":"Xiao","year":"2019","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112831_bb0170","article-title":"Structural basis for the allosteric regulation and substrate recognition of human cytosolic 5\u2032-nucleotidase II","volume":"408","author":"Karin","year":"2011","journal-title":"J. Mol. Biol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112831_bb0175","article-title":"Fludarabine metabolism by cytosolic 5\u2032-nucleotidase III and its tissue-specific localization mapping using mass spectrometry imaging","volume":"53","author":"Maisa","year":"2025","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112831_bb0180","article-title":"Small GTP-binding proteins","volume":"81","author":"Y","year":"2001","journal-title":"Physiol. Rev."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112831_bb0185","article-title":"Functional and structural insights into RAS effector proteins","volume":"84","author":"Alessandro","year":"2024","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112831_bb0190","article-title":"Targeting PI3K\/AKT\/mTOR and MAPK signaling pathways in gastric cancer","volume":"25","author":"Diana-Theodora","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"0","key":"10.1016\/j.cellsig.2026.112831_bb0195","article-title":"Novel PI3K\/Akt\/mTOR pathway inhibitors plus radiotherapy: strategy for non-small cell lung cancer with mutant RAS gene","volume":"255","author":"Kai","year":"2020","journal-title":"Life Sci."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:11:14Z","timestamp":1789690274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826004894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":39,"alternative-id":["S0898656826004894"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112831","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel peptide encoded by circTLL1 drives osimertinib resistance in lung cancer by modulating the NT5C2\/Ras\/PI3K axis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112831"}}